Saba Ghassemi
@sabaghassemi
ID: 2174642207
09-11-2013 16:01:23
66 Tweet
78 Followers
129 Following
Excited to share our new paper on generating nonactivated #CARTCell in less than 24 hrs. This innovation shifts the CART manufacturing paradigm by simplifying, expediting and making #CARTtherapy more affordable. Penn Medicine Penn Path & Lab Medicine Read more: rdcu.be/cHs6H
🧬"Exploring the Therapeutic Potential of Quiescent CAR T Cells in Cancer Immunotherapy" Thank you Dr. Saba Ghassemi, Ph.D for sharing your findings with us! What are your theories?🧬 #MedTwitter #CancerResearch
Enjoyed hanging out with the hard core #immunometabolism crew Society for Immunotherapy of Cancer #spritc2024 #springSITC
Thrilled and honored to receive my first NIH R01 grant to explore the role of IFN1 signaling in nonactivated CAR T cells. Huge thanks to nick for believing in our work. Looking forward to moving one step closer to 24-hour #CART for all. Penn Path & Lab Medicine Penn Medicine
Our new paper in Nature Biomedical Engineering: A “leukemia-on-a-chip” developed in collaboration with NYU lets us track CAR T cells in real time, seeing them act in a human-like system. Big thanks to everyone involved! Penn Medicine Penn Path & Lab Medicine nature.com/articles/s4155…
Saba Ghassemi: We did it! In memory of Mariam and Karen... #ridetoconquercancer #TheRidePHL